165 related articles for article (PubMed ID: 34913372)
1.
Santos FA; Leite-Andrade MC; Vasconcelos MA; Alves AI; Buonafina-Paz MD; Araújo-Neto LN; Macêdo DP; Neves RP
Future Microbiol; 2022 Jan; 17():81-87. PubMed ID: 34913372
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
3. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
4.
Cordeiro RA; Aguiar ALR; da Silva BN; Pereira LMG; Portela FVM; de Camargo ZP; de Lima-Neto RG; Castelo-Branco DSCM; Rocha MFG; Sidrim JJC
Front Cell Infect Microbiol; 2021; 11():645812. PubMed ID: 33968802
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
[TBL] [Abstract][Full Text] [Related]
6. Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods.
Koyanagi T; Nishida N; Osabe S; Imamura Y; Yamamoto S; Shichiji A; Nakamura Y
Pathol Int; 2006 Dec; 56(12):738-43. PubMed ID: 17096731
[TBL] [Abstract][Full Text] [Related]
7. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
[TBL] [Abstract][Full Text] [Related]
8. Trichosporon species infection in bone marrow transplanted patients.
Moretti-Branchini ML; Fukushima K; Schreiber AZ; Nishimura K; Papaiordanou PM; Trabasso P; Tanaka R; Miyaji M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):161-4. PubMed ID: 11337182
[TBL] [Abstract][Full Text] [Related]
9. Trichosporon asahii fungemia in a patient with non-hematological malignancy.
Karabay O; Madariaga MG; Kocoglu E; Ince N; Kandirali E
Jpn J Infect Dis; 2006 Apr; 59(2):129-31. PubMed ID: 16632916
[TBL] [Abstract][Full Text] [Related]
10. Fungal Bloodstream Co-infection by Trichosporon asahii in a COVID-19 Critical Patient: Case Report and Literature Review.
Benelli JL; Basso RP; Grafulha TW; Poester VR; Munhoz LS; Martins KB; Zogbi HE; Von Groll A; Severo CB; Stevens DA; Xavier MO
Mycopathologia; 2022 Aug; 187(4):397-404. PubMed ID: 35661958
[TBL] [Abstract][Full Text] [Related]
11. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
12. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
13. Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Lacasse A; Cleveland KO
Transpl Infect Dis; 2009 Apr; 11(2):155-9. PubMed ID: 18983414
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the characteristics of patients with invasive infections and noninvasive infections caused by Trichosporon asahii.
Kim J; Kim MJ; Chong YP; Kim SH; Choi SH; Lee SO; Woo JH; Kim YS; Jung J
Med Mycol; 2021 Mar; 59(3):296-300. PubMed ID: 32876327
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report.
Shang ST; Yang YS; Peng MY
J Microbiol Immunol Infect; 2010 Feb; 43(1):77-80. PubMed ID: 20434128
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
17. Chemoport-related Fungemia Caused by Trichosporon asahii.
Raju DS; Sugunan A; Keechilattu P; Philip A; Reghu R
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e193-e194. PubMed ID: 30676435
[TBL] [Abstract][Full Text] [Related]
18. Catheter-related bloodstream infections caused by Trichosporon species.
Issarachaikul R; Lertwannawit O; Detporntewan P; Uaprasert N; Plongla R; Shuangshoti S; Chindamporn A; Suankratay C
Southeast Asian J Trop Med Public Health; 2014 Mar; 45(2):421-9. PubMed ID: 24968684
[TBL] [Abstract][Full Text] [Related]
19. Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.
Cordeiro RA; Pereira LMG; de Sousa JK; Serpa R; Andrade ARC; Portela FVM; Evangelista AJJ; Sales JA; Aguiar ALR; Mendes PBL; Brilhante RSN; Sidrim JJDC; Castelo-Branco DSCM; Rocha MFG
Med Mycol; 2019 Nov; 57(8):1038-1045. PubMed ID: 30649480
[TBL] [Abstract][Full Text] [Related]
20. Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus.
Nobrega de Almeida Júnior J; Buccheri de Oliveira R; Duarte A; Lopes Motta A; Rossi F; Sachiko Yamamoto de Figueiredo D; Barbaro Del Negro GM; Aoki V; Wakisaka Maruta C; Giuli Santi C; Benard G
JAMA Dermatol; 2015 Jun; 151(6):642-5. PubMed ID: 25785367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
